Provost Ben Vinson III announced today that Miro Humer has been named the university’s vice president for [U]Tech and chief information officer. “Since he joined Case Western Reserve, Miro has ...

BOSTON, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), an immunotherapy company focused on the discovery and development of next generation therapeutics for cancer, ...

Swimming New Zealand announced on Monday that coach Lars Humer will “step back” from international coaching, with star pupil Erika Fairweather relocating to Auckland as a result. With the change, ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

NEW YORK--(BUSINESS WIRE)--Kallyope, Inc., a clinical stage biotechnology company discovering and developing novel, oral small-molecule therapeutics for diseases with high unmet need, today announced ...

(RTTNews) - 4D Molecular Therapeutics, Inc. (FDMT), a biotechnology company, Monday announced that it has appointed Kristian Humer as its new chief financial officer. Humer will be replacing Uneek ...

Mr. Humer, age 50, most recently served as chief financial officer at Foghorn Therapeutics, Inc. from April 2024 to November 2025. He was previously chief financial officer and chief business officer ...

URBANA – The director of Arrow Medical Services and Airlife for the past seven years is quitting that position to become a division chief with the Urbana Fire Department. Mick Humer, 40, of Tolono ...

The news comes after a turbulent time for the sport with the controversial departure of Ronald Claes and fears that the Limerick centre was set to be downgraded. But last night University of Limerick ...

View Wilhelm Humer’s artworks on artnet. Learn about the artist and find an in-depth biography, exhibitions, original artworks, the latest news, and sold auction prices.

NEW YORK, April 14 (Reuters) - Roche Chairman Franz Humer, the driving force behind the company's acquisition of the 44 percent of Genentech it did not already own, apparently did not always think ...

EMERYVILLE, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...